Panbela Therapeutics Inc (PBLA)
0.41
-0.02
(-4.65%)
USD |
OTCM |
May 01, 15:58
Panbela Therapeutics Total Liabilities (Quarterly): 16.51M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.51M |
| September 30, 2023 | 13.11M |
| June 30, 2023 | 14.75M |
| March 31, 2023 | 13.94M |
| December 31, 2022 | 13.03M |
| September 30, 2022 | 13.15M |
| June 30, 2022 | 11.40M |
| March 31, 2022 | 4.507M |
| December 31, 2021 | 2.66M |
| September 30, 2021 | 1.339M |
| June 30, 2021 | 1.393M |
| March 31, 2021 | 1.31M |
| December 31, 2020 | 1.365M |
| September 30, 2020 | 1.936M |
| June 30, 2020 | 1.722M |
| March 31, 2020 | 1.412M |
| December 31, 2019 | 1.759M |
| September 30, 2019 | 1.431M |
| June 30, 2019 | 1.456M |
| March 31, 2019 | 2.499M |
| December 31, 2018 | 1.63M |
| September 30, 2018 | 1.487M |
| June 30, 2018 | 1.441M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.145M |
| December 31, 2017 | 4.456M |
| September 30, 2017 | 3.632M |
| June 30, 2017 | 2.833M |
| March 31, 2017 | 2.671M |
| December 31, 2016 | 5.519M |
| September 30, 2016 | 5.151M |
| June 30, 2016 | 4.783M |
| March 31, 2016 | 4.957M |
| December 31, 2015 | 4.413M |
| September 30, 2015 | 4.03M |
| June 30, 2015 | 0.5688M |
| March 31, 2015 | 0.641M |
| December 31, 2014 | 3.794M |
| September 30, 2014 | 0.6735M |
| June 30, 2014 | 0.67M |
| March 31, 2014 | 0.6809M |
| December 31, 2013 | 0.6702M |
| September 30, 2013 | 0.66M |
| June 30, 2013 | 0.6543M |
| March 31, 2013 | 0.6589M |
| December 31, 2012 | 0.6518M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.31M
Minimum
Mar 2021
16.51M
Maximum
Dec 2023
6.220M
Average
1.936M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Processa Pharmaceuticals Inc | 0.7975M |
| Fate Therapeutics Inc | 137.80M |
| Ardelyx Inc | 130.76M |
| Checkpoint Therapeutics Inc | 18.42M |
| Palisade Bio Inc | 2.739M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.80M |
| Shareholders Equity (Quarterly) | -4.71M |